Literature DB >> 34333324

Neural signatures of saliency-mapping in anhedonia: A narrative review.

Angela Pisoni1, Simon W Davis2, Moria Smoski3.   

Abstract

Anhedonia is the loss of pleasure or motivation to engage in previously enjoyable activities, and is a transdiagnostic symptom associated with significant clinical impairment. Anhedonia is implicated in several different psychiatric disorders, presenting a promising opportunity for transdiagnostic treatment. Thus, developing targeted treatments for anhedonia is of critical importance for population mental health. An important first step in doing so is establishing a thorough understanding of the neural correlates of anhedonia. The Triple Network Model of Psychopathology provides a frame for how brain activity may go awry in anhedonia, specifically in the context of Salience Network (SN) function (i.e., saliency-mapping). We present a narrative review examining saliency-mapping as it relates to anhedonia severity in depressed and transdiagnostic adult samples. Results revealed increased anhedonia to be associated with hyperactivity of the SN at rest and in the context of negative stimuli, as well as a global lack of SN engagement in the context of positive stimuli. Potential treatments for anhedonia are placed within this model, and future directions for research are discussed.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Anhedonia; Reward processing; Salience network

Mesh:

Year:  2021        PMID: 34333324      PMCID: PMC8759627          DOI: 10.1016/j.psychres.2021.114123

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   11.225


  93 in total

1.  Research domain criteria (RDoC): toward a new classification framework for research on mental disorders.

Authors:  Thomas Insel; Bruce Cuthbert; Marjorie Garvey; Robert Heinssen; Daniel S Pine; Kevin Quinn; Charles Sanislow; Philip Wang
Journal:  Am J Psychiatry       Date:  2010-07       Impact factor: 18.112

2.  Distinct brain networks for adaptive and stable task control in humans.

Authors:  Nico U F Dosenbach; Damien A Fair; Francis M Miezin; Alexander L Cohen; Kristin K Wenger; Ronny A T Dosenbach; Michael D Fox; Abraham Z Snyder; Justin L Vincent; Marcus E Raichle; Bradley L Schlaggar; Steven E Petersen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-18       Impact factor: 11.205

3.  Ten year revision of the brief behavioral activation treatment for depression: revised treatment manual.

Authors:  C W Lejuez; Derek R Hopko; Ron Acierno; Stacey B Daughters; Sherry L Pagoto
Journal:  Behav Modif       Date:  2011-03

Review 4.  The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking.

Authors:  S Ikemoto; J Panksepp
Journal:  Brain Res Brain Res Rev       Date:  1999-12

5.  Trait anhedonia is associated with reduced reactivity and connectivity of mesolimbic and paralimbic reward pathways.

Authors:  Jennifer Keller; Christina B Young; Elizabeth Kelley; Katherine Prater; Daniel J Levitin; Vinod Menon
Journal:  J Psychiatr Res       Date:  2013-06-19       Impact factor: 4.791

6.  The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: integration of resting EEG, fMRI, and volumetric techniques.

Authors:  Jan Wacker; Daniel G Dillon; Diego A Pizzagalli
Journal:  Neuroimage       Date:  2009-02-06       Impact factor: 6.556

7.  The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.

Authors:  A John Rush; Madhukar H Trivedi; Hicham M Ibrahim; Thomas J Carmody; Bruce Arnow; Daniel N Klein; John C Markowitz; Philip T Ninan; Susan Kornstein; Rachel Manber; Michael E Thase; James H Kocsis; Martin B Keller
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

8.  Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression.

Authors:  Thomas E Schlaepfer; Michael X Cohen; Caroline Frick; Markus Kosel; Daniela Brodesser; Nikolai Axmacher; Alexius Young Joe; Martina Kreft; Doris Lenartz; Volker Sturm
Journal:  Neuropsychopharmacology       Date:  2007-04-11       Impact factor: 7.853

9.  A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia.

Authors:  Andrew D Krystal; Diego A Pizzagalli; Moria Smoski; Sanjay J Mathew; John Nurnberger; Sarah H Lisanby; Dan Iosifescu; James W Murrough; Hongqiu Yang; Richard D Weiner; Joseph R Calabrese; Gerard Sanacora; Gretchen Hermes; Richard S E Keefe; Allen Song; Wayne Goodman; Steven T Szabo; Alexis E Whitton; Keming Gao; William Z Potter
Journal:  Nat Med       Date:  2020-03-30       Impact factor: 53.440

Review 10.  Habenula: crossroad between the basal ganglia and the limbic system.

Authors:  Okihide Hikosaka; Susan R Sesack; Lucas Lecourtier; Paul D Shepard
Journal:  J Neurosci       Date:  2008-11-12       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.